The regulation of testosterone (T) between castration and supraphysiological levels suppresses cancer cell growth, thereby reducing prostate-specific antigen (PSA) and delaying castration-resistant prostate cancer progression (8). This evidence concerns the gene KLK3 and prostate cancer.